Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib

Key points – Ibrutinib may be associated with invasive fungal infections especially invasive aspergillosis. Most infections usually occur during the first months of treatment, often in patients with other risk factors for fungal infections.